1. Do we have enough evidence to specifically recommend TORS in HPV-driven oropharyngeal cancer?
- Author
-
De Virgilio, Armando, Costantino, Andrea, Rizzo, Davide, Crescio, Claudia, Gallus, Roberto, Spriano, Giuseppe, Mercante, Giuseppe, Festa, Bianca, Accorona, Remo, Pignataro, Lorenzo, Capaccio, Pasquale, and Bussu, Francesco
- Subjects
Medicine and Health Sciences - Abstract
The aim of the present study is to summarize the current evidence published in the literature concerning the role of transoral robotic surgery in oropharyngeal squamous cell carcinoma. Recently, in order to reduce the side-effects related to chemo-radiotherapy, the use of transoral robotic surgery has increased especially for oropharyngeal tumors related to HPV. Our review highlighted that, although the current evidence is not enough to clarify whether patients with HPV-positive oropharyngeal cancer treated with transoral robotic surgery have a better oncologic or functional outcome compared to those treated with radiotherapy or chemoradiotherapy, transoral robotic surgery still showed good oncological outcomes. Also, in the future transoral robotic surgery could potentially represent a promising strategy for intensifying treatments in HPV-negative oropharyngeal cancer.
- Published
- 2022
- Full Text
- View/download PDF